Development of a Clinical Prediction Model for Recurrent Anaphylaxis
Journal of Clinical Medicine · 22.05.2026 · 15 (11) · 3990
DOI: 10.3390/jcm15113990 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 22.05.2026. Verfasst von Suwannee Uthaisangsook und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Faculty of Medicine, Naresuan University, 99 Tha Pho, Mueang District, Phitsanulok 65000, Thailand. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Preventing recurrent anaphylaxis is crucial for patient safety. This study aimed to identify predictive factors and develop a prediction model to estimate recurrence risk, thereby enhancing targeted preventive strategies.
Methods
This prognostic prediction study used a retrospective observational cohort design, analyzing medical records from an anaphylaxis registry at Naresuan University Hospital, Phitsanulok, Thailand, between March 2011 and February 2021. We developed a prediction model using multivariable Cox proportional hazards regression analysis. Statistically significant and clinically relevant predictors were weighted into a risk score derived from hazard ratio regression coefficients. Model performance was evaluated using the area under the receiver operating characteristic curve (AuROC), calibration metrics, and decision curve analysis.
Results
Over the 10-year period, 381 patients experienced 439 anaphylaxis episodes, including 58 recurrences (13.2%). The final model comprised six predictors: history of food, insect, and drug allergies; asthma; chest discomfort; and severe anaphylaxis. Corresponding risk scores were 4, 5, 5.5, 1, 2.5, and 1.5 points, respectively. Total scores ranged from 0 to 19.5 and were categorized into low (9.0) risk groups. The high-risk group had a likelihood ratio positive (LHR+) of 4.65. The model demonstrated acceptable discrimination (AuROC 0.773 (95% CI: 0.714–0.832)) and good calibration. Bootstrap validation showed consistent performance (AuROC 0.773 (95% CI: 0.714–0.831)). Decision curve analysis indicated clinical utility across relevant threshold probabilities.
Conclusions
This prediction model provides a simple, clinically applicable tool for estimating the risk of recurrent anaphylaxis and may support improved prevention and management strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Faculty of Medicine, Naresuan University, 99 Tha Pho, Mueang District, Phitsanulok 65000, Thailand.
- Department of Family Medicine, Faculty of Medicine, Naresuan University, 99 Tha Pho, Mueang District, Phitsanulok 65000, Thailand.
ORCID-Profile: Suwannee Uthaisangsook, Sagoontee Inkate
Zitieren
APA
Uthaisangsook, S., Inkate, S., & Wangchiraniran, S. (2026). Development of a Clinical Prediction Model for Recurrent Anaphylaxis. Journal of Clinical Medicine, 15(11), 3990. https://doi.org/10.3390/jcm15113990
Vancouver
Uthaisangsook S, Inkate S, Wangchiraniran S. Development of a Clinical Prediction Model for Recurrent Anaphylaxis. Journal of Clinical Medicine. 2026;15(11):3990. doi:10.3390/jcm15113990
BibTeX
@article{Uthaisangsook2026,
author = {Uthaisangsook, Suwannee and Inkate, Sagoontee and Wangchiraniran, Susita},
title = {Development of a Clinical Prediction Model for Recurrent Anaphylaxis},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {11},
pages = {3990},
doi = {10.3390/jcm15113990}
}
EUVIMED